HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.350
+0.151 (4.72%)
Apr 28, 2025, 4:00 PM EDT - Market closed
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2024. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$567,804
Market Cap
3.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 15 | 3 | 25.00% |
| Apr 30, 2023 | 12 | 0 | - |
| Apr 30, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
HSCS News
- 6 weeks ago - HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications - GlobeNewsWire
- 4 months ago - HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 5 months ago - HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewsWire
- 7 months ago - HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 8 months ago - HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 8 months ago - HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - GlobeNewsWire
- 9 months ago - HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results - GlobeNewsWire